These compounds may interact with:
Serine/threonine-protein kinase 33
Potentially involved in: acquired metabolic disease; carcinoma; obesity; adult high grade glioma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; chronic rhinosinusitis; cystic fibrosis and chronic rhinosinusitis; ependymoma; glioblastoma; intraductal papillary-mucinous adenoma (ipma); lung carcinoma; medulloblastoma, large-cell; primitive neuroectodermal tumor; pancreatic neuroendocrine tumor; gastrointestinal stromal tumor; renal cell carcinoma
Disease data sourced from Pharos.